HB 1304
AN ACT relating to required labeling of certain products containing or
89th Regular Session
Jan 14, 2025 - Jun 2, 2025 • Session ended
Awaiting Committee Assignment
Bill filed, pending referral to House committee
Committee
Not yet assigned
Fiscal Note
Not available
What This Bill Does
This Texas bill requires clear labeling for food, medical, and cosmetic products that contain, are manufactured using, or derived from human fetal tissue obtained from abortions. Manufacturers, sellers, and distributors of these products in Texas must label them conspicuously according to rules established by the Texas Health and Human Services Commission by December 1, 2025. The law will apply to products sold, dispensed, or administered on or after January 1, 2026, affecting businesses in food, medical, and cosmetic industries that use such tissue in their products.
Subject Areas
Bill Text
relating to required labeling of certain products containing or derived from aborted human fetal tissue. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subchapter D, Chapter 431, Health and Safety Code, is amended by adding Section 431.085 to read as follows: Sec. 431.085. LABELING REQUIRED FOR FETAL TISSUE FOOD PRODUCT. (a) In this section: (1) "Fetal tissue food product" means a food or food (A) contains human fetal tissue; (B) is manufactured using human fetal tissue; or (C) is otherwise derived from research using (2) "Human fetal tissue" means tissue, cells, including cells from fetal cell lines, or organs obtained or originally derived from an aborted unborn child. (b) A person may not sell in this state a fetal tissue food product unless the product is clearly and conspicuously labeled in accordance with department rules. (c) The executive commissioner by rule shall prescribe the form and contents of the label required by Subsection (b). SECTION 2. Subchapter E, Chapter 431, Health and Safety Code, is amended by adding Section 431.118 to read as follows: Sec. 431.118. LABELING REQUIRED FOR FETAL TISSUE MEDICAL PRODUCT. (a) In this section: (1) "Fetal tissue medical product" means a medication, vaccine, or other medical product used in medical treatment that: (A) contains human fetal tissue; (B) is manufactured using human fetal tissue; or (C) is otherwise derived from research using (2) "Human fetal tissue" means tissue, cells, including cells from fetal cell lines, or organs obtained or originally derived from an aborted unborn child. (b) A person may not sell, dispense, or administer in this state a fetal tissue medical product unless the product is clearly and conspicuously labeled in accordance with department rules. (c) The executive commissioner by rule shall prescribe the form and contents of the label required by Subsection (b). SECTION 3. Subchapter F, Chapter 431, Health and Safety Code, is amended by adding Section 431.143 to read as follows: Sec. 431.143. LABELING REQUIRED FOR FETAL TISSUE COSMETIC PRODUCT. (a) In this section: (1) "Fetal tissue cosmetic product" means a cosmetic (A) contains human fetal tissue; (B) is manufactured using human fetal tissue; or (C) is otherwise derived from research using (2) "Human fetal tissue" means tissue, cells, including cells from fetal cell lines, or organs obtained or originally derived from an aborted unborn child. (b) A person may not sell in this state a fetal tissue cosmetic product unless the product is clearly and conspicuously labeled in accordance with department rules. (c) The executive commissioner by rule shall prescribe the form and contents of the label required by Subsection (b). SECTION 4. (a) Not later than December 1, 2025, the executive commissioner of the Health and Human Services Commission shall adopt the form and content of the labels required under Sections 431.085, 431.118, and 431.143, Health and Safety Code, as (b) Sections 431.085, 431.118, and 431.143, Health and Safety Code, as added by this Act, apply only to a fetal tissue product sold, dispensed, or administered on or after January 1, SECTION 5. This Act takes effect immediately if it receives a vote of two-thirds of all the members elected to each house, as provided by Section 39, Article III, Texas Constitution. If this Act does not receive the vote necessary for immediate effect, this Act takes effect September 1, 2025.
Bill Sponsors
Legislators who authored or co-sponsored this bill.
Expert Lobbyists for This Bill
These lobbyists specialize in Abortion and related subject areas.
Erika Ramirez
Brianna M. Menard
Ky Ash
Felix Chevalier
Christopher Hughes
Bill Jones
Carrie Kroll
Gavin L. Massingill
David Doran Parker
Andrea G. Sparks
Bill History
Bill filed: AN ACT relating to required labeling of certain products containing or
Related Guides
Learn more about tracking Texas legislation and working with lobbyists.
How to Read & Track Texas Bills
Master bill numbering, understand legislative language, and learn effective tracking strategies.
Understanding Texas Legislative Deadlines
Navigate the 140-day session with critical calendar dates and filing deadlines.
How Laws Get Made in Texas
Follow a bill's journey from filing to the governor's desk through committees and floor votes.
When Should Your Business Hire a Lobbyist?
Discover the signs that your business needs professional advocacy at the Texas Capitol.